rubidium chloride rb-82
Approved
Dec 29, 1989
Rubidium Rb-82 is a radioactive isotope of rubidium. It is widely used for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in adult patients with suspected or existing coronary artery disease. Rb-82 decays by positron emission and associated gamma emission with a physical half-life of 75 seconds. In biochemical behavior, it is analogous to potassium ion (K+) and is rapidly extracted by the myocardium proportional to the blood flow. Rb+ participates in the sodium-potassium (Na+/K+) ion exchange pumps that are present in cell membranes. 82 radioactivity in viable myocardium is higher than in infarcted tissue, reflecting intracellular retention. Rubidium 82 chloride was approved by the FDA and is marketed under a trade name Ruby-Fill and Cardiogen-82. — NCATS
Clinical trial activity
10 trials · 11 clinical orgs · 3 marketing orgs
Earliest trial started Nov 1, 2006 (NCT01254591)
Timeline
1980s
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
- Jan 1, 2011
Earliest Phase 3 Sponsor(trial)
- Sep 30, 2016
Jubilant DraxImage Inc. — NDA Secondary Org
- Sep 30, 2016
Jubilant DraxImage Inc. — Marketing Organization
- Sep 30, 2016
Jubilant Innovation Ltd. — NDA Secondary Org
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- contrast mediumRadiopaque
contrast medium radiopaque
Approval history
- approvedDec 29, 1989
Chemistry & pharmacology
SMILES
[Cl-].[Rb+]- Mol. weight
- 120.92 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL2110557 ↗
- WikipediaRubidium-82 chloride ↗
- NCATS550Z839889 ↗
- ChEMBLCHEMBL1200727 ↗
Also known as
- 82rbcl
- 82rbcl
- cardiogen
- cardiogen
- cardiogen-82
- cardiogen-82
- cardiogen-82
- cardiogen-82
- cardiogen-82
- rb82
- rb-82
- rubidium
- rubidium
- rubidium-82
- rubidium-82
- rubidium-82 chloride
- rubidium (82rb) chloride
- rubidium (82rb) chloride
- rubidium (82rb) chloride
- rubidium chloride
- rubidium chloride
- rubidium chloride (82rb)
- rubidium chloride (82rb)
- rubidium chloride rb 82
- rubidium chloride rb 82
- rubidium chloride rb 82
- rubidium chloride rb-82
- rubidium chloride rb-82
- rubidium rb-82 chloride
- rubidium rb-82 chloride
- rubidium rb-82 chloride
- rubidium rb-82 chloride
- ruby-fill
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06965621 | Phase 2 | Nov 30, 2025 | Illumina, Inc., University of Texas, Galveston |
| NCT05286593 | Phase 4 | Dec 28, 2021 | Bracco, Ochsner Health System |
| NCT03236311 | Phase 2 | Oct 12, 2017 | Sanofi |
| NCT03048097 | Phase 2 | Feb 1, 2017 | Yale University |
| NCT01919450 | Phase 4 | Jul 1, 2013 | Cardiovascular Imaging Technologies |
| NCT01679886 | N/A | Sep 1, 2012 | University of Paris |
| NCT01648933 | N/A | Jul 1, 2012 | University of Paris |
| NCT01433705 | Phase 1 | Nov 1, 2011 | University of Michigan |
| NCT01379677 | Phase 3 | Feb 1, 2011 | Advanced Accelerator Applications, University of London |
| NCT01254591 | N/A | Nov 1, 2006 | University of London |
Organizations
Research & Development (11)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of London | Academic/Hospital | 2 | 1 | 2 | 2006 |
| University of Paris | Academic/Hospital | 2 | 2 | 1 | 2012 |
| Advanced Accelerator Applications | For profit | 1 | 1 | 1 | 2011 |
| Bracco | For profit | 1 | 0 | 1 | 2021 |
| Cardiovascular Imaging Technologies | For profit | 1 | 1 | 1 | 2013 |
| Illumina, Inc. | For profit | 1 | 1 | 1 | 2025 |
| Ochsner Health System | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Sanofi | For profit | 1 | 1 | 1 | 2017 |
| University of Michigan | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Texas, Galveston | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Yale University | Academic/Hospital | 1 | 1 | 1 | 2017 |
Marketing (5)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Bracco | For profit | NDA2 | Dec 29, 1989 |
| Bracco | For profit | NDA | Dec 29, 1989 |
| Jubilant DraxImage Inc. | For profit | NDA2 | Sep 30, 2016 |
| Jubilant DraxImage Inc. | For profit | MKTG | Sep 30, 2016 |
| Jubilant Innovation Ltd. | For profit | NDA2 | Sep 30, 2016 |